The Journal of Thoracic and Cardiovascular Surgery
Volume 140, Issue 1 , Pages 188-195, July 2010

Leukoreduction program for red blood cell transfusions in coronary surgery: Association with reduced acute kidney injury and in-hospital mortality

  • Gianpaolo Romano, MD

      Affiliations

    • Department of Cardiothoracic Sciences, Second University of Naples, Naples, Italy
  • ,
  • Ciro Mastroianni, MD

      Affiliations

    • Department of Cardiovascular Surgery and Transplants, V. Monaldi Hospital, Naples, Italy
  • ,
  • Ciro Bancone, MD

      Affiliations

    • Department of Cardiovascular Surgery and Transplants, V. Monaldi Hospital, Naples, Italy
  • ,
  • Alessandro Della Corte, MD, PhD, FEACTS

      Affiliations

    • Department of Cardiovascular Surgery and Transplants, V. Monaldi Hospital, Naples, Italy
  • ,
  • Nicola Galdieri, MD

      Affiliations

    • Department of Cardiothoracic Sciences, Second University of Naples, Naples, Italy
  • ,
  • Gianantonio Nappi, FEACTS

      Affiliations

    • Department of Cardiovascular Surgery and Transplants, V. Monaldi Hospital, Naples, Italy
  • ,
  • Luca Salvatore De Santo, FEACTS

      Affiliations

    • Cardiac Surgery, University of Foggia, Foggia, Italy
    • Corresponding Author InformationAddress for reprints: Luca Salvatore De Santo, FEACTS, Viale Colli Aminei 491, 80131, Naples, Italy.

Received 18 October 2009; received in revised form 17 February 2010; accepted 14 March 2010. published online 23 April 2010.

Objective

Leukocytes in allogeneic blood transfusions cause several immunomodulatory events. This before-and-after cohort study evaluated clinical outcomes after adoption of prestorage leukoreduction program for blood transfusions, with particular focus on acute kidney injury.

Methods

One thousand thirty-four consecutive patients who underwent on-pump coronary artery bypass grafting between January 2004 and December 2007 were included. Propensity score analysis for transfusion was performed in the whole population; patients who were actually transfused were then divided according to leukoreduction. From these 2 groups, 147 pairs matched for propensity score were considered to evaluate with bivariate and multivariable analyses the effects of leukoreduction, with all-cause in-hospital mortality and morbidity as main outcomes.

Results

Unadjusted in-hospital mortalities were 6.6% for the entire cohort and 44.2% for those with acute kidney injury. In the matched population, after introduction of leukoreduction, mortality rates decreased to 5.4% (vs 11.4%) and acute kidney injury (RIFLE [Risk, Injury, Failure, Loss of function, End-stage renal disease] class R or greater) dropped from 51.7% to 41.5% (relative risk −20%, P < .045). No difference emerged regarding other major complications. At multivariable analysis, intra-aortic balloon pump, RIFLE score, and propensity score for transfusion proved independent predictors of in-hospital mortality. Intra-aortic balloon pump and nonleukodepleted transfusion emerged as independent predictors of acute kidney injury. Multivariable analysis on the overall cohort of transfused patients confirmed that nonleukodepleted transfusion was an independent predictor of acute kidney injury.

Conclusions

Leukoreduction of allogeneic blood products is associated with decreased acute kidney injury and mortality in highly transfused patients.

CTSNet classification: 23, 37, 41

Abbreviations and Acronyms: CABG, coronary artery bypass grafting, CSA-AKI, cardiac surgery–associated acute kidney injury, GFR, glomerular filtration rate, IABP, intra-aortic balloon pump, RBC, red blood cell, RIFLE, Risk, Injury, Failure, Loss of function, End-stage renal disease

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Disclosures: None.

PII: S0022-5223(10)00317-X

doi:10.1016/j.jtcvs.2010.03.022

The Journal of Thoracic and Cardiovascular Surgery
Volume 140, Issue 1 , Pages 188-195, July 2010